Publications by authors named "Gary Bloomgren"

Claim this Profile
E
Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018.
Priya Jain, Kimberley McKinnell, Rose Marino, Prashanthi Vunnava, Marie A Liles-Burden, Gary Bloomgren

Drug Saf· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".
Bernard Silverman, Gary Bloomgren, Priya Jain, Kimberley Marcopul, Alexandra Silveira

Drug Saf· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.
Susan Friend, Sandra Richman, Gary Bloomgren, Lynda M Cristiano, Madé Wenten

BMC Neurol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Tuan Dong-Si, Sarah Gheuens, Amy Gangadharan, Made Wenten, Jeffrey Philip, Gary Bloomgren

J Neurovirol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Tatiana Plavina, Meena Subramanyam, Gary Bloomgren, Sandra Richman, Amy Pace

Ann Neurol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Tuan Dong-Si, Sandra Richman, Mike P Wattjes, Made Wenten, Sarah Gheuens, Gary Bloomgren

Ann Clin Transl Neurol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
Gary Bloomgren, Bjørn Sperling, Kimberly Cushing, Madé Wenten

Ther Clin Risk Manag· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Gary Bloomgren, Sandra Richman, Christophe Hotermans, Meena Subramanyam, Susan Goelz

N Engl J Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1.
Carmen Bozic, Sandra Richman, Tatiana Plavina, Amy Natarajan, James V Scanlon, Gary Bloomgren

Ann Neurol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study.
Rebecca A Noel, Daniel K Braun, Ruth E Patterson, Gary L Bloomgren

Diabetes Care· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis